CoChat

Loading neural stem cells on hydrogel scaffold improves cell retention rate and promotes functional recovery in traumatic brain injury

Chen, Tiange, Xia, Yuguo, Zhang, Liyang, Xu, Tao, Yi, Yan, Chen, Jianwei, Liu, Ziyuan, Yang, Liting, Chen, Siming, Zhou, Xiaoxi, Chen, Xin, Wu, Haiyu, Liu, Jinfang · 2023 · Materials Today Bio
Cited by 42

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Neural stem cell (NSC) has gained considerable attention in traumatic brain injury (TBI) treatment because of their ability to replenish dysfunctional neurons and stimulate endogenous neurorestorative processes. However, their therapeutic effects are hindered by the low cell retention rate after transplantation into the dynamic brain. In this study, we found cerebrospinal fluid (CSF) flow after TBI is an important factor associated with cell loss following NSC transplantation. Recently, several studies have shown that hydrogels could serve as a beneficial carrier for stem cell transplantation, which provides a solution to prevent CSF flow-induced cell loss after TBI. For this purpose, we evaluated three different hydrogel scaffolds and found the gelatin methacrylate (GelMA)/sodium alginate (Alg) (GelMA/Alg) hydrogel scaffold showed the best capabilities for NSC adherence, growth, and differentiation. Additionally, we detected that pre-differentiated NSCs, which were loaded on the GelMA/Alg hydrogel and cultured for 7 days in neuronal differentiation medium (NSC [7d]), had the highest cell retention rate after CSF impact. Next, the neuroprotective effects of the NSC-loaded GelMA/Alg hydrogel scaffold were evaluated in a rat model of TBI. NSC [7d]-loaded GelMA/Alg markedly decreased microglial activation and neuronal death in the acute phase, reduced tissue loss, alleviated astrogliosis, promoted neurogenesis, and improved neurological recovery in the chronic phase. In summary, we demonstrated that the integration with the GelMA/Alg and modification of NSC differentiation could inhibit the influence of CSF flow on transplanted NSCs, leading to increased number of retained NSCs and improved neuroprotective effects, providing a promising alternative for TBI treatment.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.mtbio.2023.100606

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 58

  1. Albayram, 2017, Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae, Nat. Commun., 8, 1000, 10.1038/s41467-017-01068-4 · DOI · Paper page
  2. 2019, Injury, C. Spinal Cord Injury, Global, regional, and national burden of traumatic brain injury and spinal cord injury, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol., 18, 56, 10.1016/S1474-4422(18)30415-0 · DOI · Paper page
  3. Wu, 2019, NT3(P75-2) gene-modified bone mesenchymal stem cells improve neurological function recovery in mouse TBI model, Stem Cell Res. Ther., 10, 311, 10.1186/s13287-019-1428-1 · DOI
  4. Zhou, 2020, Promoting 3D neuronal differentiation in hydrogel for spinal cord regeneration, Colloids Surf. B Biointerfaces, 194, 10.1016/j.colsurfb.2020.111214 · DOI
  5. Feng, 2017, Bone marrow stromal cells promote neuromotor functional recovery, via upregulation of neurotrophic factors and synapse proteins following traumatic brain injury in rats, Mol. Med. Rep., 16, 654, 10.3892/mmr.2017.6619 · DOI
  6. Yao, 2019, A dual-enzymatically cross-linked injectable gelatin hydrogel loaded with BMSC improves neurological function recovery of traumatic brain injury in rats, Biomater. Sci., 7, 4088, 10.1039/C9BM00749K · DOI
  7. Skardelly, 2011, Long-term benefit of human fetal neuronal progenitor cell transplantation in a clinically adapted model after traumatic brain injury, J. Neurotrauma, 28, 401, 10.1089/neu.2010.1526 · DOI
  8. Mahmood, 2011, Treatment of TBI with collagen scaffolds and human marrow stromal cells increases the expression of tissue plasminogen activator, J. Neurotrauma, 28, 1199, 10.1089/neu.2010.1694 · DOI
  9. Gupta, 2009, Three-dimensional computational modeling of subject-specific cerebrospinal fluid flow in the subarachnoid space, J. Biomech. Eng., 131, 10.1115/1.3005171 · DOI · Paper page
  10. Bao, 2018, Stimulation of chondrocytes and chondroinduced mesenchymal stem cells by osteoinduced mesenchymal stem cells under a fluid flow stimulus on an integrated microfluidic device, Mol. Med. Rep., 17, 2277
  11. Jing, 2021, Effects of compound stimulation of fluid shear stress plus ultrasound on stem cell proliferation and osteogenesis, Regen Biomater, 8, 10.1093/rb/rbab066 · DOI
  12. Gupta, 2018, Role of geometrical cues in bone marrow-derived mesenchymal stem cell survival, growth and osteogenic differentiation, J. Biomater. Appl., 32, 906, 10.1177/0885328217745699 · DOI
  13. Xue, 2017, Acoustic tweezing cytometry enhances osteogenesis of human mesenchymal stem cells through cytoskeletal contractility and YAP activation, Biomaterials, 134, 22, 10.1016/j.biomaterials.2017.04.039 · DOI
  14. Bellotti, 2021, Injectable thermoresponsive hydrogels as drug delivery system for the treatment of central nervous system disorders: a review, J. Contr. Rel. : Official J. Control. Rel. Soc., 329, 16, 10.1016/j.jconrel.2020.11.049 · DOI · Paper page
  15. Choudhury, 2018, Organ-derived decellularized extracellular matrix: a game changer for bioink manufacturing?, Trends Biotechnol., 36, 787, 10.1016/j.tibtech.2018.03.003 · DOI · Paper page
  16. Heinrich, 2019, 3D bioprinting: from benches to translational applications, Small, 15
  17. Zhao, 2020, Preliminary engineering for in situ in vivo bioprinting: a novel micro bioprinting platform for in situ in vivo bioprinting at a gastric wound site, Biofabrication, 12, 10.1088/1758-5090/aba4ff · DOI · Paper page
  18. Puckert, 2020, Molecular interactions and forces of adhesion between single human neural stem cells and gelatin methacrylate hydrogels of varying stiffness, Acta Biomater., 106, 156, 10.1016/j.actbio.2020.02.023 · DOI
  19. Jin, 2021, Engineering the fate and function of human T-Cells via 3D bioprinting, Biofabrication, 13, 10.1088/1758-5090/abd56b · DOI
  20. Feng, 2020, Three-dimensional printing of hydrogel scaffolds with hierarchical structure for scalable stem cell culture, ACS Biomater. Sci. Eng., 6, 2995, 10.1021/acsbiomaterials.9b01825 · DOI
  21. Wang, 2017, Systematic characterization of porosity and mass transport and mechanical properties of porous polyurethane scaffolds, J. Mech. Behav. Biomed. Mater., 65, 657, 10.1016/j.jmbbm.2016.09.029 · DOI
  22. Zhang, 2019, Three-dimensional (3D) printed scaffold and material selection for bone repair, Acta Biomater., 84, 16, 10.1016/j.actbio.2018.11.039 · DOI · Paper page
  23. Xia, 2018, Tissue plasminogen activator promotes white matter integrity and functional recovery in a murine model of traumatic brain injury, Proc. Natl. Acad. Sci. U. S. A., 115, E9230, 10.1073/pnas.1810693115 · DOI · Paper page
  24. Wang, 2021, Injectable silk sericin scaffolds with programmable shape-memory property and neuro-differentiation-promoting activity for individualized brain repair of severe ischemic stroke, Bioact. Mater., 6, 1988
  25. Nih, 2018, Dual-function injectable angiogenic biomaterial for the repair of brain tissue following stroke, Nat. Mater., 17, 642, 10.1038/s41563-018-0083-8 · DOI · Paper page
  26. Zheng, 2021, Neuro-regenerative imidazole-functionalized GelMA hydrogel loaded with hAMSC and SDF-1alpha promote stem cell differentiation and repair focal brain injury, Bioact. Mater., 6, 627
  27. Luo, 2021, Application of bioactive hydrogels combined with dental pulp stem cells for the repair of large gap peripheral nerve injuries, Bioact. Mater., 6, 638
  28. Augst, 2006, Alginate hydrogels as biomaterials, Macromol. Biosci., 6, 623, 10.1002/mabi.200600069 · DOI · Paper page
  29. Jiang, 2019, Post-stroke administration of omega-3 polyunsaturated fatty acids promotes neurovascular restoration after ischemic stroke in mice: efficacy declines with aging, Neurobiol. Dis., 126, 62, 10.1016/j.nbd.2018.09.012 · DOI · Paper page
  30. Genet, 2021, Understanding neural stem cell regulation in vivo and applying the insights to cell therapy for strokes, Regen. Med., 16, 861, 10.2217/rme-2021-0022 · DOI
  31. Jiang, 2019, Traumatic brain injury in China, Lancet Neurol., 18, 286, 10.1016/S1474-4422(18)30469-1 · DOI · Paper page
  32. Jia, 2021, Niche cells crosstalk in neuroinflammation after traumatic brain injury, Int. J. Biol. Sci., 17, 368, 10.7150/ijbs.52169 · DOI
  33. Lengel, 2020, Stem cell therapy for pediatric traumatic brain injury, Front. Neurol., 11, 10.3389/fneur.2020.601286 · DOI
  34. Ahmed, 2016, Stem cells for therapy in TBI, J. Roy. Army Med. Corps, 162, 98, 10.1136/jramc-2015-000475 · DOI
  35. Mashkouri, 2016, Utilizing pharmacotherapy and mesenchymal stem cell therapy to reduce inflammation following traumatic brain injury, Neural regeneration research, 11, 1379, 10.4103/1673-5374.191197 · DOI
  36. Gao, 2016, Human neural stem cell transplantation-mediated alteration of microglial/macrophage phenotypes after traumatic brain injury, Cell Transplant., 25, 1863, 10.3727/096368916X691150 · DOI
  37. Yasuhara, 2020, Cell therapy for central nervous system disorders: current obstacles to progress, CNS Neurosci. Ther., 26, 595, 10.1111/cns.13247 · DOI
  38. Lalou, 2020, Cerebrospinal fluid dynamics in non-acute post-traumatic ventriculomegaly, Fluids Barriers CNS, 17, 24, 10.1186/s12987-020-00184-6 · doi:10.1186/s12987-020-00184-6
  39. Borlongan, 2011, The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disorders, Prog. Neurobiol., 95, 213, 10.1016/j.pneurobio.2011.08.005 · DOI · Paper page
  40. Reynolds, 1992, Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system, Science (New York, N.Y.), 255, 1707, 10.1126/science.1553558 · DOI · Paper page
  41. Temple, 2001, The development of neural stem cells, Nature, 414, 112, 10.1038/35102174 · DOI · Paper page
  42. Fan, 2018, Directing induced pluripotent stem cell derived neural stem cell fate with a three-dimensional biomimetic hydrogel for spinal cord injury repair, ACS Appl. Mater. Interfaces, 10, 17742, 10.1021/acsami.8b05293 · DOI · Paper page
  43. Abeysinghe, 2015, Pre-differentiation of human neural stem cells into GABAergic neurons prior to transplant results in greater repopulation of the damaged brain and accelerates functional recovery after transient ischemic stroke, Stem Cell Res. Ther., 6, 186, 10.1186/s13287-015-0175-1 · DOI · Paper page
  44. McLeod, 2013, Transplantation of GABAergic cells derived from bioreactor-expanded human neural precursor cells restores motor and cognitive behavioral deficits in a rodent model of Huntington's disease, Cell Transplant., 22, 2237, 10.3727/096368912X658809 · DOI
  45. McGraw, 2001, Modulating astrogliosis after neurotrauma, J. Neurosci. Res., 63, 109, 10.1002/1097-4547(20010115)63:2<109::AID-JNR1002>3.0.CO;2-J · DOI · Paper page
  46. Mira, 2021, Traumatic brain injury: mechanisms of glial response, Front. Physiol., 12, 10.3389/fphys.2021.740939 · DOI · Paper page
  47. Liu, 2021, Cell therapy for neurological disorders: the perspective of promising cells, Biology, 10, 1142, 10.3390/biology10111142 · DOI
  48. Payne, 2019, Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain, Biomaterials, 192, 309, 10.1016/j.biomaterials.2018.11.020 · DOI
  49. Bonilla, 2021, Cell-Based therapies for traumatic brain injury: therapeutic treatments and clinical trials, Biomedicines, 9, 669, 10.3390/biomedicines9060669 · DOI · Paper page
  50. Schepici, 2020, Traumatic brain injury and stem cells: an overview of clinical trials, the current treatments and future therapeutic approaches, Medicina, 56, 10.3390/medicina56030137 · DOI
  51. Zhou, 2019, Advance of stem cell treatment for traumatic brain injury, Front. Cell. Neurosci., 13, 301, 10.3389/fncel.2019.00301 · DOI
  52. Walker, 2010, Progenitor cell therapy for the treatment of central nervous system injury: a review of the state of current clinical trials, Stem Cell. Int., 2010
  53. Hausser, 2018, Detecting behavioral deficits in rats after traumatic brain injury, J. Vis. Exp., 131
  54. Yang, 2017, ST2/IL-33-Dependent microglial response limits acute ischemic brain injury, J. Neurosci., 37, 4692, 10.1523/JNEUROSCI.3233-16.2017 · DOI · Paper page
  55. Niclis, 2017, Long-distance a xonal growth and protracted functional maturation of neurons derived from human induced pluripotent stem cells after intracerebral transplantation, Stem Cells Transl Med, 6, 1547, 10.1002/sctm.16-0198 · DOI
  56. Hu, 2015, Microglial and macrophage polarization-new prospects for brain repair, Nat. Rev. Neurol., 11, 56, 10.1038/nrneurol.2014.207 · DOI · Paper page
  57. Donat, 2017, Microglial activation in traumatic brain injury, Front. Aging Neurosci., 9, 208, 10.3389/fnagi.2017.00208 · DOI · Paper page
  58. Cheng, 2016, Anti-inflammatory mechanism of neural stem cell transplantation in spinal cord injury, Int. J. Mol. Sci., 17, 1380, 10.3390/ijms17091380 · DOI · Paper page

Cited by

Metadata

Authors
Chen, T., Xia, Y., Zhang, L., Xu, T., Yi, Y., Chen, J., Liu, Z., Yang, L., Chen, S., Zhou, X., Chen, X., Wu, H., & Liu, J.
Venue
Materials Today Bio
Publisher
Elsevier BV
Published
2023-04
Volume
19
Pages
100606
ISSN
2590-0064
Cited by
42
References
7
Language
en
Licence
Funders
  • National Natural Science Foundation of China (81402249, 82201543)
  • China Postdoctoral Science Foundation (2022M723562)
  • Natural Science Foundation of Hunan Province (2019JJ50963, 2020SK2070, 2021JJ31080, 2022JJ40828)
  • Xiangya Hospital, Central South University (2021Q01)
  • National Postdoctoral Program for Innovative Talents (BX20220356)
  • Natural Science Foundation of Changzhou City (kq2202377)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.